Mission NEEV (Neonatal Early Evaluation Vision)

Introduction And Rationale

Definition: Mission NEEV is a comprehensive, digitally integrated newborn screening and surveillance initiative.
Implementing Agency: Launched by the Government of NCT of Delhi, supported by the Delhi State Health Mission, and functioning under the broader umbrella of the Rashtriya Bal Swasthya Karyakram (RBSK).
Target Demographic: Aimed at universally screening institutional deliveries (covering approximately 1.5 lakh newborns annually in its primary phase).
Core Rationale: To transition from a reactive healthcare model to a proactive, preemptive strategy, ensuring the early detection of anomalies that cause significant neonatal mortality or long-term severe morbidity (e.g., intellectual disability, sudden cardiac death).

Early Identification: To screen every newborn for visible, functional, and metabolic birth defects before facility discharge.
Digital Tracking: To establish a seamless, centralized digital database (NEEV Portal) for tracking, recall, and epidemiological surveillance.
Timely Intervention: To ensure immediate linkage to tertiary care for identified cases, strictly aligning with the “Catch Early, Treat Early” mandate.

Timing: Conducted within the first 24 to 48 hours of birth.
Clinical Scope: A meticulous, standardized head-to-toe physical examination to identify structural congenital anomalies (e.g., Neural tube defects, cleft lip and palate, clubfoot, Down syndrome phenotype).
Digital Logging: The clinical findings are logged directly into a dedicated VBD screening mobile application by the nursing staff.

Targets critical systemic dysfunctions that are phenotypically silent at birth:

Hearing Evaluation (Otoacoustic Emissions - OAE):
- Conducted on day 2 or 3 of life.
- Ensures early detection of congenital deafness, allowing for timely interventions (cochlear implants or hearing aids) to preserve speech and language development.
Critical Congenital Heart Disease (CCHD) Screening:
- Utilizes Pulse Oximetry on day 2 or 3 of life.
- Pre-ductal (right hand) and post-ductal (either foot) SpO2 are recorded to detect ductus-dependent systemic or pulmonary circulatory defects.
Vision Assessment:
- Screening for Retinopathy of Prematurity (ROP) in eligible premature/low birth weight infants utilizing digital retinal imaging.

Focuses on highly prevalent, life-threatening, but easily treatable Inborn Errors of Metabolism (IEM):

Congenital Hypothyroidism (CH): Early levothyroxine initiation prevents irreversible intellectual disability.
Congenital Adrenal Hyperplasia (CAH): Prevents fatal salt-wasting crises and ambiguous genitalia complications.
G6PD Deficiency: Prevents severe neonatal hyperbilirubinemia and subsequent kernicterus.
Methodology: Heel-prick dried blood spot (DBS) collection is performed, ideally synchronized with routine birth vaccinations to minimize pain, strictly prior to discharge.

The hallmark of Mission NEEV is its robust IT infrastructure, specifically designed to eliminate loss to follow-up:

Unique VBD Identifier Generation: At the first structural screening, a unique VBD ID is generated, permanently linking the mother’s demographic data to the infant.
Interconnected Mobile Applications: Nursing staff utilize specific, Bluetooth-linked mobile apps (OAE app, PO app, Metabolic app) that automatically sync diagnostic instrument readings directly to the centralized NEEV server.
Barcoded Sample Tracking: Blood samples are tagged with specific VBD barcodes, significantly preventing pre-analytical clerical errors in the laboratory.
Centralized Portal And Recall System:
All results are securely stored on the cloud-based NEEV portal.
Automated SMS alerts are dispatched to parents for repeat testing, confirmatory diagnostics, or regular follow-up visits.
If a child visits a different integrated health facility, the VBD ID allows the treating pediatrician seamless access to the entire neonatal screening history.

Recall Mechanism: Infants failing the initial OAE or Pulse Oximetry screens are recalled for repeat testing or definitive diagnostics (e.g., BERA for hearing, 2D-Echocardiography for CCHD) within a stipulated timeframe.
Confirmatory Testing: Positive metabolic screens (e.g., elevated TSH or 17-OHP) trigger immediate serum confirmatory testing and pediatric endocrinology referral.
Integration With DEIC: Diagnosed infants are seamlessly linked to District Early Intervention Centers (DEIC) under the RBSK for zero-cost, long-term multidisciplinary management.

Elimination Of Manual Data Entry: Direct Bluetooth integration from screening devices to the portal minimizes human transcription errors.
Universal Portability: The cloud-based database allows any empaneled hospital to access the child’s records, which is crucial for migrant or highly mobile urban populations.
Epidemiological Mapping: Provides the government with real-time, high-fidelity incidence data of congenital and metabolic anomalies, effectively guiding future resource allocation and health policy.